Magle Chemoswed Q3: Initial take - Redeye

Redeye leaves an initial comment following the Q3 report published by Magle this morning. The company reported a y/y sales growth, but slightly below our net sales estimates. While OPEX and COGS were in line with our expectations, this resulted in a lower EBIT than expected. However, despite this, we do not expect to make any major adjustments to our long-term forecasts.

Länk till analysen i sin helhet: https://www.redeye.se/research/949910/magle-chemoswed-q3-initial-take?utm_source=finwire&utm_medium=RSS